ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism
Recommendations
As issued by the authors
Suggestions to optimize levothyroxine (LT4) treatment in monotherapy, with individualization of treatment as the key point
Nutritional, pharmacological and pathological factors potentially increasing LT4 need are discussed, with a specific focus on liquid and softgel formulations
Original publication
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism. Eur Thyroid J. Published 7 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →